Endoscopic Bariatric and Metabolic Therapy Fellowship Program

1. Medical degree: MD, DO, or equivalent medical qualification.
2. Prior specialty training: Completion of the required Gastroenterology fellowship/training for advanced endoscopic practice.
3. Clinical/GME eligibility: Must satisfy Cedars-Sinai Graduate Medical Education and credentialing requirements.
4. Licensure: Must be eligible for the required U.S./California medical licensure and clinical privileges.
5. International medical graduates: Must meet applicable ECFMG certification and U.S. licensing requirements.
6. Program-specific requirements: The public Cedars-Sinai page does not currently publish a detailed eligibility checklist, so any additional requirements should be confirmed directly with the program. Cedars-Sinai's physician application materials require applicants to meet its medical-staff and clinical-privilege requirements.

The Endoscopic Bariatric and Metabolic Therapy Fellowship at Cedars-Sinai Medical Center provides specialized training in endoscopic approaches to the management of obesity and metabolic diseases. The program focuses on advanced bariatric endoscopic procedures, patient evaluation and selection, peri-procedural care, and multidisciplinary management of patients with obesity and related metabolic conditions. Fellows also gain experience in clinical decision-making, research, and collaboration with specialists involved in comprehensive obesity care.

1. Complete the required Gastroenterology training.
2. Prepare your CV, personal statement, academic records and letters of recommendation.
3. Confirm eligibility for Cedars-Sinai GME, California licensure and clinical privileges.
4. Submit the fellowship application through the application method specified by Cedars-Sinai.
5. The program reviews applications and supporting documents.
6. Shortlisted candidates are invited for an interview.
7. Selected candidates complete credentialing, licensing and onboarding.
8. Begin the Endoscopic Bariatric and Metabolic Therapy Fellowship at Cedars-Sinai.